F Magro, R Bastos, M Marques, C Costa Santos. Show Affiliations »
Abstract
Mesh： See more » AdultAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/pharmacokineticsC-Reactive Protein/metabolismCrohn Disease/drug therapyCrohn Disease/metabolismDose-Response Relationship, DrugDrug Administration ScheduleFollow-Up StudiesGastrointestinal Agents/administration & dosageGastrointestinal Agents/pharmacokineticsHumansInfliximabInfusions, IntravenousMiddle AgedRetrospective StudiesSeverity of Illness IndexTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances： See more » Antibodies, MonoclonalGastrointestinal AgentsTumor Necrosis Factor-alphaC-Reactive ProteinInfliximab
Year: 2008 PMID： 18022873 DOI： 10.1002/ibd.20314
Source DB: PubMed Journal: Inflamm Bowel Dis ISSN： 1078-0998 Impact factor: 5.325